The Hidden Dangers: Superabsorbent Polymer Beads as a Cause of Bowel Obstruction in Children

SaraPettey Sandifer1, Alicia C Greene2, Quincy Erturk1

  • 1The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.

PubMed

Insights

Superabsorbent polymer (SAP) bead ingestion can cause dangerous bowel obstruction in children. In vitro studies show hyperosmolar agents and osmotic laxatives can shrink these beads, potentially avoiding surgery.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Materials Science

Background:

  • Superabsorbent polymer (SAP) bead ingestion is a significant risk for children, often leading to bowel obstruction.
  • Surgical intervention is frequently required for SAP bead-induced intestinal blockages.

Purpose of the Study:

  • To review existing literature on pediatric SAP bead ingestion and bowel obstruction.
  • To investigate in vitro strategies for contracting enlarged SAP beads to potentially prevent surgery.

Main Methods:

  • Conducted a literature review of SAP bead ingestion cases in children.
  • Performed an in vitro experiment using SAP beads in a simulated intestinal environment.
  • Tested various hyperosmolar agents and osmotic laxatives for their bead size reduction efficacy.

Main Results:

  • Identified 87 pediatric cases of SAP bead-induced bowel obstruction, with ultrasound being more effective for diagnosis than radiography.
  • 85.6% of patients required surgical enterotomy, and reoperations were common.
  • In vitro, GoLYTELY reduced SAP bead size by 35.17% within 24 hours, outperforming other tested agents.

Conclusions:

  • SAP beads present a considerable risk to pediatric patients, necessitating prompt management.
  • Hyperosmolar agents and osmotic laxatives show promise in reducing SAP bead size, potentially offering a non-surgical treatment option.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
574
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
621
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
724
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
529
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
634